Coronavirus disease 2019 in Latin American patients with multiple sclerosis
Copyright © 2021 Elsevier B.V. All rights reserved..
Patients with multiple sclerosis (MS) who present coronavirus disease 2019 (COVID-19) are of particular interest to neurologists. These patients have a neuroimmune disease and receive immunomodulatory or immunosuppressive therapies in the long-term. We present here data from 73 patients with MS and a confirmed diagnosis of COVID-19 from five Latin American countries. Fifteen patients (20.5%) were hospitalized and two patients died. The use of anti-CD20 therapies was the only risk factor associated to hospitalization and death. Despite the small sample size, this study highlights the awareness regarding therapeutic options for MS during the pandemic.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:55 |
|---|---|
| Enthalten in: |
Multiple sclerosis and related disorders - 55(2021) vom: 24. Okt., Seite 103173 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Fragoso, Yara D [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Completed 19.10.2021 Date Revised 19.10.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.msard.2021.103173 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM328770418 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM328770418 | ||
| 003 | DE-627 | ||
| 005 | 20231225203642.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.msard.2021.103173 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1095.xml |
| 035 | |a (DE-627)NLM328770418 | ||
| 035 | |a (NLM)34332462 | ||
| 035 | |a (PII)S2211-0348(21)00440-5 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Fragoso, Yara D |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Coronavirus disease 2019 in Latin American patients with multiple sclerosis |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 19.10.2021 | ||
| 500 | |a Date Revised 19.10.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2021 Elsevier B.V. All rights reserved. | ||
| 520 | |a Patients with multiple sclerosis (MS) who present coronavirus disease 2019 (COVID-19) are of particular interest to neurologists. These patients have a neuroimmune disease and receive immunomodulatory or immunosuppressive therapies in the long-term. We present here data from 73 patients with MS and a confirmed diagnosis of COVID-19 from five Latin American countries. Fifteen patients (20.5%) were hospitalized and two patients died. The use of anti-CD20 therapies was the only risk factor associated to hospitalization and death. Despite the small sample size, this study highlights the awareness regarding therapeutic options for MS during the pandemic | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Multiple sclerosis | |
| 650 | 4 | |a Pandemic | |
| 650 | 4 | |a ocrelizumab | |
| 650 | 4 | |a rituximab | |
| 700 | 1 | |a Schiavetti, Irene |e verfasserin |4 aut | |
| 700 | 1 | |a Carmisciano, Luca |e verfasserin |4 aut | |
| 700 | 1 | |a Ponzano, Marta |e verfasserin |4 aut | |
| 700 | 1 | |a Steinberg, Judith |e verfasserin |4 aut | |
| 700 | 1 | |a Treviño-Frenk, Irene |e verfasserin |4 aut | |
| 700 | 1 | |a Ciampi, Ethel |e verfasserin |4 aut | |
| 700 | 1 | |a Vecino, Maria Cecilia A |e verfasserin |4 aut | |
| 700 | 1 | |a Correa, Edgar P |e verfasserin |4 aut | |
| 700 | 1 | |a Carcamo, Claudia |e verfasserin |4 aut | |
| 700 | 1 | |a Gomes, Sidney |e verfasserin |4 aut | |
| 700 | 1 | |a Pimentel, Maria Lucia V |e verfasserin |4 aut | |
| 700 | 1 | |a Santos, Gutemberg A C |e verfasserin |4 aut | |
| 700 | 1 | |a Vrech, Carlos |e verfasserin |4 aut | |
| 700 | 1 | |a Winckler, Thereza C A |e verfasserin |4 aut | |
| 700 | 1 | |a Sormani, Maria Pia |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Multiple sclerosis and related disorders |d 2012 |g 55(2021) vom: 24. Okt., Seite 103173 |w (DE-627)NLM219118388 |x 2211-0356 |7 nnns |
| 773 | 1 | 8 | |g volume:55 |g year:2021 |g day:24 |g month:10 |g pages:103173 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.msard.2021.103173 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 55 |j 2021 |b 24 |c 10 |h 103173 | ||